Vyne Therapeutics logo

Vyne Therapeutics Share Price Today

(NASDAQ: VYNE)

Vyne Therapeutics share price is $1.41 & ₹120.12 as on 30 Apr 2025, 2.30 'hrs' IST

$1.41

-0.03

(-2.08%)

Market is closed - opens 7 PM, 30 Apr 2025

View live Vyne Therapeutics share price in Dollar and Rupees. Guide to invest in Vyne Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vyne Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Vyne Therapeutics share price movements

  • Today's Low: $1.38
    Today's High: $1.50

    Day's Volatility :7.69%

  • 52 Weeks Low: $1.28
    52 Weeks High: $4.30

    52 Weeks Volatility :70.23%

Vyne Therapeutics (VYNE) Returns

PeriodVyne Therapeutics IncIndex (Russel 2000)
3 Months
-43.2%
0.0%
6 Months
-47.99%
0.0%
1 Year
-43.65%
0.0%
3 Years
-80.99%
-5.1%

Vyne Therapeutics (VYNE) Key Statistics

in dollars & INR

Previous Close
$1.44
Open
$1.42
Today's High
$1.495
Today's Low
$1.38
Market Capitalization
$28.6M
Today's Volume
$212.7K
52 Week High
$4.3
52 Week Low
$1.28
Revenue TTM
$501.0K
EBITDA
$-43.6M
Earnings Per Share (EPS)
$-0.93
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-56.54%

How to invest in Vyne Therapeutics Stock (VYNE) from India?

It is very easy for Indian residents to invest directly in Vyne Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vyne Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vyne Therapeutics or VYNE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vyne Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vyne Therapeutics shares which would translate to 0.604 fractional shares of Vyne Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vyne Therapeutics, in just a few clicks!

Returns in Vyne Therapeutics (VYNE) for Indian investors in Rupees

The Vyne Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vyne Therapeutics investment value today

Current value as on today

₹55,701

Returns

₹44,299

(-44.3%)

Returns from Vyne Therapeutics Stock

₹46,388 (-46.39%)

Dollar Returns

₹2,089 (+2.09%)

Indian investors sentiment towards Vyne Therapeutics (VYNE)

133%

Period: Mar 30, 2025 to Apr 29, 2025. Change in 30 Days versus previous period

Search interest for Vyne Therapeutics Stock from India on INDmoney has increased by 133% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Vyne Therapeutics

  • Eventide Asset Management, LLC

    9.17%

  • Cormorant Asset Management, LLC

    9.17%

  • Citadel Advisors Llc

    8.09%

  • Dsc Advisors LP

    4.58%

  • Vanguard Group Inc

    3.12%

  • Palo Alto Investors, LLC

    2.93%

Analyst Recommendation on Vyne Therapeutics

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Vyne Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Vyne Therapeutics Stock (VYNE)

What analysts predicted

Upside of 352.13%

Target:

$6.38

Current:

$1.41

Insights on Vyne Therapeutics Stock (Ticker Symbol: VYNE)

  • Price Movement

    In the last 7 days, VYNE stock has moved down by -23.7%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 198.0K → 84.0K (in $), with an average decrease of 34.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -12.15M → -12.02M (in $), with an average increase of 1.1% per quarter
  • VYNE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 73.0% return, outperforming this stock by 119.0%
  • VYNE vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 91.0% return, outperforming this stock by 172.2%
  • Price to Sales

    ForVYNE every $1 of sales, investors are willing to pay $117.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.6 for every $1 of sales.

Vyne Therapeutics Technicals Summary

Sell

Neutral

Buy

Vyne Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Vyne Therapeutics (VYNE) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Vyne Therapeutics Inc logo
-10.13%
-47.99%
-43.65%
-80.99%
-98.66%
Regeneron Pharmaceuticals, Inc. logo
-3.5%
-33.68%
-31.29%
-6.14%
16.46%
Beone Medicines Ltd logo
-8.24%
21.23%
62.23%
49.96%
78.11%
Vertex Pharmaceuticals Incorporated logo
2.53%
4.63%
26.54%
89.75%
95.01%
Alnylam Pharmaceuticals, Inc. logo
-5.61%
-9.46%
77.05%
83.29%
97.62%

About Vyne Therapeutics

VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company's lead program is repibresib gel (VYN201), a topically administered small molecule pan-bromodomain and extra-terminal (BET) inhibitor soft drug to address diseases involving multiple and diverse inflammatory cell signaling pathways with low systemic exposure. It also develops VYN202, a BD2-selective oral small molecule BET inhibitor in Phase 1b trial for the acute control and chronic management of immune-mediated inflammatory conditions. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.
Organization
Vyne Therapeutics
Employees
13
CEO
Mr. David T. Domzalski
Industry
Health Technology

Management People of Vyne Therapeutics

NameTitle
Mr. David T. Domzalski
CEO, President & Director
Dr. Iain A. Stuart Ph.D.
Chief Scientific Officer
Ms. Mutya Harsch J.D.
General Counsel, Chief Legal Officer & Company Secretary
Mr. Tyler Zeronda CPA
CFO & Treasurer
Dr. Darrell S. Rigel FAAD, M.D.
Consultant

Important FAQs about investing in VYNE Stock from India :

What is Vyne Therapeutics share price today?

Vyne Therapeutics share price today stands at $1.41, Open: $1.42 ; Previous Close: $1.44 ; High: $1.50 ; Low: $1.38 ; 52 Week High: $4.30 ; 52 Week Low: $1.28.

The stock opens at $1.42, after a previous close of $1.44. The stock reached a daily high of $1.50 and a low of $1.38, with a 52-week high of $4.30 and a 52-week low of $1.28.

Can Indians buy Vyne Therapeutics shares?

Yes, Indians can invest in the Vyne Therapeutics (VYNE) from India.

With INDmoney, you can buy Vyne Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Vyne Therapeutics at zero transaction cost.

How can I buy Vyne Therapeutics shares from India?

It is very easy to buy Vyne Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vyne Therapeutics (VYNE) be purchased?

Yes, you can buy fractional shares of Vyne Therapeutics with INDmoney app.

What are the documents required to start investing in Vyne Therapeutics stocks?

To start investing in Vyne Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Vyne Therapeutics Stock (VYNE)?

Today’s highest price of Vyne Therapeutics (VYNE) is $1.50.

Today’s lowest price of Vyne Therapeutics (VYNE) is $1.38.

What is today's market capitalisation of Vyne Therapeutics?

Today's market capitalisation of Vyne Therapeutics VYNE is 28.6M

What is the 52 Week High and Low Range of Vyne Therapeutics Stock (VYNE)?

  • 52 Week High

    $4.30

  • 52 Week Low

    $1.28

What are the historical returns of Vyne Therapeutics (VYNE)?

  • 1 Month Returns

    -10.13%

  • 3 Months Returns

    -47.99%

  • 1 Year Returns

    -43.65%

  • 5 Years Returns

    -98.66%

Who is the Chief Executive Officer (CEO) of Vyne Therapeutics ?

Mr. David T. Domzalski is the current Chief Executive Officer (CEO) of Vyne Therapeutics.